Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis.
売上高(百万円)167
期末従業員数
6 人
本社住所Chapman Street Unit 10, 25-37 Blackburn North Melbourne Victoria Australia
投稿したコメント